Table of Contents
1. Executive Summary
2. Global Digital Pathology Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Digital Pathology Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Digital Pathology Market by Product
3.3.1: Scanners
3.3.1.1: Brightfield
3.3.1.2: Other Scanners
3.3.2: Software
3.3.2.1: Integrated Software
3.3.2.2: Standalone Software
3.3.2.2.1: Information Management Software
3.3.2.2.2: Image Analysis Software
3.3.3: Storage Systems
3.4: Global Digital Pathology Market by Type
3.4.1: Human Pathology
3.4.2: Veterinary Pathology
3.5: Global Digital Pathology Market by Application
3.5.1: Drug Discovery
3.5.2: Disease Diagnosis
3.5.3: Training & Education
3.6: Global Digital Pathology Market by End Use
3.6.1: Pharmaceutical & Biotechnology Companies
3.6.2: Hospitals and Reference Laboratories
3.6.3: Academic & Research Institutes
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Digital Pathology Market by Region
4.2: North American Digital Pathology Market
4.2.1: North American Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.2.2: North American Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
4.3: European Digital Pathology Market
4.3.1: European Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.3.2: European Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
4.4: APAC Digital Pathology Market
4.4.1: APAC Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.4.2: APAC Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
4.5: ROW Digital Pathology Market
4.5.1: ROW Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.5.2: ROW Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Digital Pathology Market by Product
6.1.2: Growth Opportunities for the Global Digital Pathology Market by Type
6.1.3: Growth Opportunities for the Global Digital Pathology Market by Application
6.1.4: Growth Opportunities for the Global Digital Pathology Market by End Use
6.1.5: Growth Opportunities for the Global Digital Pathology Market by Region
6.2: Emerging Trends in the Global Digital Pathology Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Digital Pathology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Pathology Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Leica Biosystems
7.2: Koninklijke Philips N.V.
7.3: Hamamatsu Photonics
7.4: F. Hoffmann-La Roche
7.5: 3DHISTECH
7.6: Apollo Enterprise Imaging
7.7: XIFIN
7.8: Visiopharm A/S
7.9: Aiforia Technologies Oy
7.10: Akoya Biosciences
7.11: Corista